LRCX HOLD at 1% weight with $300 stop and bull trigger at $337 on volume as structural bid balanced against macro/EPS headwinds
Unanimous HOLD verdict across all three analysts aligned with Research Manager's plan and trader's proposal. Structural-bid franchise thesis (record FY26: $23.2B revenue, 50.5% gross margin, 35.3% operating margin, 65.1% ROE, $1.85B net cash, $5B+ annual buybacks, sold-out backlog) forecloses Underweight. Forward EPS math (28x P/E requiring ~104% normalization, FCF conversion collapse 1.11x → 0.67x, P/B 33x) and hostile macro (10Y 5.14%) forecloses aggressive Buy. The $297-307 add zone remains live per 9/29 binding lesson, but binary earnings catalyst in late October is structural reason to remain at current weight until confirmation rather than pre-emptively trim into strength that has not yet resolved. Price target $343.
| Position | Action |
|---|---|
| 1% portfolio target | Lower end of 1-2% band (1% weight) — appropriate for 1.86 beta with hostile macro |
LRCX is in a structural reset driven by AI-related semiconductor capex (HBM, GAA, advanced NAND), not a normal WFE cycle, with the stock already having absorbed macro headwinds and now poised for further appreciation as earnings catch up to the price.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $310.91 | bullish |
| 50 SMA | $304.80 | neutral |
| 200 SMA | $272.79 | bullish |
| MACD | +3.34 | bullish |
| MACD Signal | −1.65 | neutral |
| MACD Histogram | +5.00 | bullish |
| RSI (14) | 61.43 | bullish |
| Bollinger Upper Band | $337.18 | neutral |
| Bollinger Middle Band | $299.88 | neutral |
| Bollinger Lower Band | $262.57 | neutral |
| ATR (14) | $13.98 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
↩ rebuts: “Bear '55x P/E is stretched' thesis”
EV: +22% (from ~$328 to $400+) · concedes: 55x trailing P/E is elevated (but compressing into forward earnings); Beta 1.86 and ATR $14 make this volatile; Volume confirmation above $337 has not yet occurred; FY27 digestion risk exists; Recession probability (8%) is rising
LRCX is at a cycle peak with maximum profitability metrics, extreme forward EPS assumptions, and macro headwinds — the asymmetry of risk/reward is decisively negative, requiring perfection from the bull but only mean reversion from the bear.
EV: -$170 to -$128 (target $250-$260 from $328 current price; possible $200-$220 if bear-flag fully resolves) · concedes: The bear acknowledges beta 'cuts both ways' mathematically; The bear acknowledges that if EPS doubles to $11.74, multiple stays at 28x, macro stabilizes, and volume confirms breakout above $337, the stock could reach $400+ — but calls this 'perfection required'
→ vs conservative: Waiting for 200 SMA at $272 for better entry is wrongheaded; if LRCX tags $272 something fundamental has broken and you'll want to know why before buying
→ vs conservative: FCF/Net Income decline from 1.11x to 0.67x is cyclical working capital mechanics from record $6.7B quarterly shipments, not structural cash flow problem; calling it structural at AI capex cycle peak misses the move
→ vs conservative: 10-year at 5.14% with LRCX rallying 14% off lows proves market already priced rate risk and is looking through to 2027 capex cycle
→ vs conservative: Revenue grew 26% to record $23.2 billion and bears complain about $1.96B receivables build—can't ship $6.7B in a quarter without 60-90 day payment terms
→ vs neutral: Waiting for $337 breakout confirmation turns 60% winners into 8% winners; you'll be buying upper third of move by then
→ vs neutral: Waiting for symmetry in inherently asymmetric setup is leaving money on the table dressed up as prudence
→ vs neutral: Light volume on recovery is healthy, not concerning—capitulation volume already occurred at July lows; heavy recovery volume would actually signal move overextended
→ vs neutral: MACD fresh bullish crossover, RSI at 61 not overbought, ATR compressed 50%, golden cross forming—all dismissed by neutral waiting for $337 confirmation
| bullish |
| ATR Peak | $28.87 | neutral |
| Close Price | $328.51 | neutral |
| Volume (2026-09-30) | 7.66M shares | neutral |
Support: 337.18 · 330.5 · 314.47 · 310.91 · 304.8 · 299.88 · 289.89 · 272.79 · 262.57 | Resistance: 262.57 · 272.79 · 289.89 · 299.88 · 304.8 · 310.91 · 314.47 · 330.5 · 337.18
The FINAL TRANSACTION PROPOSAL is HOLD. LRCX is in a post-crash recovery phase with multiple bullish momentum confirmations (MACD cross at +3.34, RSI recovering from 31 to 61, price above 10 EMA and 50 SMA, ATR compressing from $28 peak to $14). However, the 50 SMA has not yet turned upward, the recovery rally has come on light volume, and upper Bollinger Band resistance at $337.18 remains untested. Key support levels are clustered at $310.91 (10 EMA), $304.80 (50 SMA), and $299.88 (20 SMA/Bollinger mid), while resistance sits at $330.50 intraday high and $337.18 upper Bollinger Band. A 2× ATR stop (~$28 below entry) is recommended given elevated daily volatility.
Market Capitalization
$411.1 B
P/E (TTM)
55.4x
Forward P/E
28.0x
P/B
33.0x
PEG Ratio
1.51
Dividend Yield
0.41%
Beta
1.86
Revenue (FY2023)
$17,429 M
Revenue (FY2024)
$14,905 M
Revenue (FY2025)
$18,436 M
Revenue (FY2026)
$23,233 M
Gross Profit (FY2026)
$11,725 M
EBITDA (FY2023)
$5,638 M
EBITDA (FY2024)
$4,905 M
EBITDA (FY2025)
$6,523 M
EBITDA (FY2026)
$8,861 M
Net Income (FY2023)
$4,511 M
Net Income (FY2024)
$3,828 M
Net Income (FY2025)
$5,358 M
Net Income (FY2026)
$7,265 M
Diluted EPS (FY2023)
$3.32
Diluted EPS (FY2024)
$2.90
Diluted EPS (FY2025)
$4.15
Diluted EPS (FY2026)
$5.76
Diluted EPS (Q4 FY2026)
$1.81
Revenue (Q4 FY2026)
$6.72B
Gross Margin (Q4 FY2026)
51.7%
Operating Margin (Q4 FY2026)
37.4%
Return on Equity
65.1%
Return on Assets
22.8%
Cash & Equivalents (FY2026)
$5,579 M
Total Debt (FY2026)
$3,735 M
Net Cash Position
~$1,844 M
Stockholders' Equity (FY2026)
$12,471 M
Current Ratio
2.63x
Working Capital (FY2026)
$9,673 M
Goodwill + Intangibles (FY2026)
$1,896 M
Operating Cash Flow (FY2026)
$5,858 M
CapEx (FY2026)
$966 M
Free Cash Flow (FY2026)
$4,891 M
FCF/Revenue
21.1%
Share Repurchases (FY2026)
$3,851 M
Dividends (FY2026)
$1,271 M
Total Capital Return (FY2026)
~$5.12 B
Diluted Shares Outstanding
1,261 M
Treasury Stock (FY2023)
$21.5 B
Treasury Stock (FY2026)
$31.6 B
3-Year Revenue CAGR
~10.1%
3-Year EPS CAGR
~20.0%
Latest Quarter Revenue Growth (YoY)
+29.7%
Latest Quarter EPS Growth (YoY)
+34.1%
R&D as % of Revenue (FY2026)
~10.2%
52-Week High
$438.50
52-Week Low
$131.02
50-Day Moving Average
$304.95
200-Day Moving Average
$272.45
Strengths
Concerns
Lam Research Corporation delivered exceptional FY2026 results with record revenue of $23.23B (+26% YoY), gross margins expanding to 50.5%, and diluted EPS of $5.76 — all driven by AI/HBM capex tailwinds and share gains in advanced etch/deposition for gate-all-around logic and 3D NAND stacking. The company maintains a fortress balance sheet with $1.84B net cash, generates robust free cash flow of $4.89B, and returned $5.12B to shareholders via buybacks ($3.85B) and dividends ($1.27B), reducing diluted shares by 7.2% over three years. Despite best-in-class fundamentals and an accelerating revenue trajectory (Q4 FY2026 hit $6.72B, up 29.7% YoY), the stock trades at stretched multiples of 55x trailing P/E and 33x P/B, leaving limited margin of safety if the WFE up-cycle moderates — prompting a HOLD rating with a recommendation to wait for pullbacks toward the 200-day MA (~$272) before adding positions.
Macro: Rates & Yields: 10Y Treasury at 5.14% (highest of cycle, triggered by stronger-than-expected September business activity data); 30Y at highest level since 2002; Mortgage rates near 7.58% (approaching 3-year high). Fed Policy: Polymarket shows 97% probability of no Fed rate cuts in 2026 ($8.7M traded); all cut-count buckets (6, 9, 10, 11, 12+) priced at 0%. Inflation & Activity: Mixed — cooler-than-expected inflation read briefly supported tech, but stronger activity data pushed yields higher; S&P and Dow posted monthly losses in September. Recession Tail Risk: US recession by end-2026 at 8% (+1pp week-over-week); UK at 10% (-3pp wk); Japan at 5% (+0.5pp wk). Cross-Asset: Tech/AI complex outperformed on cooler inflation but clipped by 10Y surge (two-way tape); falling oil and easing yields stabilized equities Friday; Trump-Xi \"tech titan dinner\" briefly reduced China-decoupling tail risk; Polymarket shows only 13% probability of US gov't stake in TSMC, 13% in NVIDIA, 4% in Samsung — low disruption odds.